SCHEMBL9681672

SCHEMBL9681672

CCn1c(=O)[nH]c(=O)c2c1ncn2CCCCC1COC(C)(C)O1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ PDE4A P27815 4/20 0.52
▸ ADORA2A P29274 4/20 0.52
▸ PDE4B Q07343 4/20 0.52
▸ PDE4C Q08493 4/20 0.52
▸ PDE4D Q08499 4/20 0.52
▸ BRD4 O60885 7/20 0.49
▸ BRD2 P25440 2/20 0.49
▸ BRD3 Q15059 2/20 0.49
▸ BRDT Q58F21 2/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9683380 0.93 ADORA2A (0.62) ALDH1A1MEN1KMT2APDE4AADORA2A
SCHEMBL9682956 0.89 SMN1; SMN2 (0.52) ALDH1A1MEN1KMT2APDE4AADORA2A
SCHEMBL10811479 0.84 ADORA2A (0.44) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL10811527 0.83 PDE4A (0.46) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL10810766 0.83 ADORA2A (0.43) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL10814264 0.82 ADORA2A (0.49) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL10813975 0.80 PDE4A (0.46) MEN1KMT2APDE4AADORA2APDE4B
SCHEMBL17682330 0.77 ALDH1A1 (0.58) ALDH1A1MEN1KMT2APDE4AADORA2A
SCHEMBL7031729 0.76 MEN1 (0.87) ALDH1A1MEN1KMT2APDE4AADORA2A
SCHEMBL7464482 0.74 PDE4A (0.86) ALDH1A1MEN1KMT2APDE4AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5082845-A Gastrointestinal HOECHST JAPAN LIMITED (JP) 1992-01-21 — — US disclosed
EP-0330031-B1 THERAPEUTIC AGENTS FOR THE TREATMENT OF PEPTIC ULCER DISEASE HOECHST JAPAN LIMITED (JP) 1991-12-11 — — EP disclosed
EP-0330031-A1 Therapeutic agents for the treatment of peptic ulcer disease HOECHST JAPAN LIMITED (JP) 1989-08-30 — — EP disclosed
US-4713455-A FOR OBSTRUCTIVE DISORDERS OF THE RESPIRATORY TRACT HOECHST AKTIENGESELLSCHAFT (DE) 1987-12-15 — — US disclosed
US-4616020-A TREATING OBSTRUCTIVE RESPIRATORY DISEASES HOECHST AKTIENGESELLSCHAFT (DE) 1986-10-07 — — US disclosed
EP-0075850-B1 PHARMACEUTICAL PREPARATIONS CONTAINING VICINAL DIHYDROXYALKYL XANTHINES, PROCESS FOR THE PREPARATION OF THE XANTHINES AND THE APPROPRIATE INTERMEDIATES THEREFOR HOECHST AKTIENGESELLSCHAFT (DE) 1985-12-18 — — EP disclosed
EP-0075850-A2 Pharmaceutical preparations containing vicinal dihydroxyalkyl xanthines, process for the preparation of the xanthines and the appropriate intermediates therefor HOECHST AKTIENGESELLSCHAFT (DE) 1983-04-06 — — EP disclosed
Send feedback